Spina E - Search Results

1

The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: a double-blind, placebo-controlled study.

Zoccali R, Muscatello MR, Bruno A, Cambria R, Micò U, Spina E, Meduri M. Zoccali R, et al. Among authors: spina e. Schizophr Res. 2007 Jul;93(1-3):109-16. doi: 10.1016/j.schres.2007.02.009. Epub 2007 Mar 26. Schizophr Res. 2007. PMID: 17383857 Clinical Trial.

2

Polymorphic debrisoquine oxidation and acute neuroleptic-induced adverse effects.

Spina E, Ancione M, Di Rosa AE, Meduri M, Caputi AP. Spina E, et al. Eur J Clin Pharmacol. 1992;42(3):347-8. doi: 10.1007/BF00266363. Eur J Clin Pharmacol. 1992. PMID: 1349529 No abstract available.

3

Debrisoquine oxidation phenotype and neuroleptic-induced dystonic reactions.

Spina E, Sturiale V, Valvo S, Ancione M, Di Rosa AE, Meduri M, Caputi AP. Spina E, et al. Acta Psychiatr Scand. 1992 Nov;86(5):364-6. doi: 10.1111/j.1600-0447.1992.tb03281.x. Acta Psychiatr Scand. 1992. PMID: 1485526

4

Single dose pharmacokinetics of carbamazepine-10,11-epoxide in patients on lamotrigine monotherapy.

Pisani F, Xiao B, Fazio A, Spina E, Perucca E, Tomson T. Pisani F, et al. Among authors: spina e. Epilepsy Res. 1994 Dec;19(3):245-8. doi: 10.1016/0920-1211(94)90068-x. Epilepsy Res. 1994. PMID: 7698101

5

Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients.

Spina E, De Domenico P, Ruello C, Longobardo N, Gitto C, Ancione M, Di Rosa AE, Caputi AP. Spina E, et al. Int Clin Psychopharmacol. 1994 Winter;9(4):281-5. doi: 10.1097/00004850-199400940-00007. Int Clin Psychopharmacol. 1994. PMID: 7868850 Clinical Trial.

6

Prevalence of acute dystonic reactions associated with neuroleptic treatment with and without anticholinergic prophylaxis.

Spina E, Sturiale V, Valvo S, Ancione M, Di Rosa AE, Meduri M, Caputi AP. Spina E, et al. Int Clin Psychopharmacol. 1993 Spring;8(1):21-4. doi: 10.1097/00004850-199300810-00003. Int Clin Psychopharmacol. 1993. PMID: 8097213

7

Epidemiology and pathoetiology of neurological syndromes with hyperthermia.

Di Rosa AE, Morgante L, Spina E, Meduri M. Di Rosa AE, et al. Among authors: spina e. Funct Neurol. 1995 May-Jun;10(3):111-9. Funct Neurol. 1995. PMID: 8557212 Review. No abstract available.

8

Interaction between fluoxetine and haloperidol: pharmacokinetic and clinical implications.

Avenoso A, Spinà E, Campo G, Facciolă G, Ferlito M, Zuccaro P, Perucca E, Caputi AP. Avenoso A, et al. Among authors: spina e. Pharmacol Res. 1997 Apr;35(4):335-9. Pharmacol Res. 1997. PMID: 9264051 Clinical Trial.

9

Effect of fluoxetine on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenia.

Spina E, Avenoso A, Facciolà G, Fabrazzo M, Monteleone P, Maj M, Perucca E, Caputi AP. Spina E, et al. Int Clin Psychopharmacol. 1998 May;13(3):141-5. doi: 10.1097/00004850-199805000-00009. Int Clin Psychopharmacol. 1998. PMID: 9690983

10

Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders.

Facciolà G, Avenoso A, Scordo MG, Madia AG, Ventimiglia A, Perucca E, Spina E. Facciolà G, et al. Among authors: spina e. Ther Drug Monit. 1999 Jun;21(3):341-5. doi: 10.1097/00007691-199906000-00017. Ther Drug Monit. 1999. PMID: 10365650 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

412 results

Search Page

Filters